Browsing by Author "Armoiry, Xavier"
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
Item Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis : systematic review and economic evaluation(2017-09-01) Melendez-Torres, G. J.; Auguste, Peter; Armoiry, Xavier; Maheswaran, Hendramoorthy; Court, Rachel; Madan, Jason; Kan, Alan; Lin, Stephanie; Counsell, Carl; Patterson, Jacoby; Rodrigues, Jeremy; Ciccarelli, Olga; Fraser, Hannah; Clarke, Aileen; University of Aberdeen.Chronic Disease Research Group; University of Aberdeen.Grampian Data Safe Haven (DaSH); University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Other Applied Health SciencesItem Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis : systematic review and network meta-analysis of trials including recommended dosages(2018-10-03) Melendez-Torres, G. J.; Armoiry, Xavier; Court, Rachel; Patterson, Jacoby; Kan, Alan; Auguste, Peter; Madan, Jason; Counsell, Carl; Ciccarelli, Olga; Clarke, Aileen; University of Aberdeen.Grampian Data Safe Haven (DaSH); University of Aberdeen.Chronic Disease Research Group; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Institute of Applied Health SciencesItem EMA and NICE Appraisal Processes for Cancer Drugs : Current Status and Uncertainties(2018-08) Dickson, Rumona; Boland, Angela; Duarte, Rui; Kotas, Eleanor; Woolacott, Nerys; Hodgson, Robert; Riemsma, Rob; Grimm, Sabine; Ramaekers, Bram; Joore, Manuela; Büyükkaramikli, Nasuh; Kaltenthaler, Eva; Stevenson, Matt; Pandor, Abdullah; Edwards, Steve; Hoyle, Martin; Shepherd, Jonathan; Armoiry, Xavier; Brazzelli, Miriam; University of Aberdeen.Aberdeen Centre for Evaluation; University of Aberdeen.Institute of Applied Health SciencesItem Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? : A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis(2022-12-13) Armoiry, Xavier; Wang-Steverding, Xia; Connock, Martin; Grove, Amy; Clarke, Aileen; Arun, Tarunya; Counsell, Carl; Auguste, Peter; University of Aberdeen.Institute of Applied Health Sciences; University of Aberdeen.Chronic Disease Research Group; University of Aberdeen.Other Applied Health SciencesItem Ocrelizumab not recommended in France for patients with primary progressive multiple sclerosis while recommended in England : a review comparing the assessment by HAS and NICE(2021-06-03) Armoiry, Xavier; Späth, Hans-Martin; Henaine , Anna-Maria; Dussart, Claude; Counsell, Carl; Connock, Martin; University of Aberdeen.Grampian Data Safe Haven (DaSH); University of Aberdeen.Chronic Disease Research Group; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Institute of Applied Health SciencesItem Short and long-term clinical outcomes of use of beta-interferon or glatiramer acetate for people with clinically isolated syndrome : a systematic review of randomised controlled trials and network meta-analysis(2018-05) Armoiry, Xavier; Kan, Alan; Melendez-Torres, G. J.; Court, Rachel; Sutcliffe, P; Auguste, Peter; Madan, Jason; Counsell, Carl; Clarke, A.; University of Aberdeen.Other Applied Health Sciences; University of Aberdeen.Chronic Disease Research Group; University of Aberdeen.Grampian Data Safe Haven (DaSH); University of Aberdeen.Institute of Applied Health Sciences